Business
Medpace Holdings, Inc. to Present at Baird’s Global Healthcare Conference
CINCINNATI--(BUSINESS WIRE)-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference:
About this update from Medpace Holdings, Inc.
[{"type":"text","content":" CINCINNATI--(BUSINESS WIRE)--\nMedpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will present at the following investor conference:\n\nBaird’s Global Healthcare Conference\nDate: Tuesday, September 14, 2021\nPresentation: 8:30 a.m. ET\nSpeakers: Jesse Geiger, President, and Kevin Brady, Chief Financial Officer\n\nA live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.medpace.com and will be available for replay following the event.\n\nAbout Medpace\n\nMedpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,100 people across 40 countries as of June 30, 2021.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210830005516/en/\n\nInvestor Contact:\nLauren Morris\n513.579.9911 x11994\[email protected]\n\nMedia Contact:\nJulie Hopkins\n513.579.9911 x12627\[email protected]\n\nSource: Medpace Holdings, Inc.","length":3082,"tagName":"div"}]